Control of silk microsphere formation using polyethylene glycol (PEG)
Source abstract
Abstract
Unlabelled A one step, rapid method to prepare silk microspheres was developed, with particle size controlled by the addition of polyethylene glycol (PEG). PEG molecular weight (4.0K-20.0KDa) and concentration (20-50wt%), as well as silk concentration (5-20wt%), were key factors that determined particle sizes varying in a range of 1-100μm. Addition of methanol to the PEG-silk combinations increased the content of crystalline β-sheet in the silk microspheres. To track the distribution and degradation of silk microspheres in vivo, 3-mercaptopropionic acid (MPA)-coated CdTe quantum dots (QDs) were physically entrapped in the silk microspheres. QDs tightly bound to the β-sheet domains of silk via hydrophobic interactions, with over 96% of the loaded QDs remaining in the silk microspheres after exhaustive extraction. The fluorescence of QDs-incorporated silk microspheres less stable in cell culture medium than in phosphate buffer solution (PBS) and water. After subcutaneous injection in mice, microspheres prepared from 20% silk (approx. 30μm diameter particles) still fluoresced at 24h, while those prepared from 8% silk (approx. 4μm diameter particles) and free QDs were not detectable, reflecting the QDs quenching and particle size effect on microsphere clearance in vivo. The larger microspheres were more resistant to cell internalization and degradation. Since PEG is an FDA-approved polymer, and silk is FDA approved for some medical devices, the methods developed in the present study will be useful in a variety of biomedical applications where simple, rapid and scalable preparation of silk microspheres is required. Statement of significance The work is of significance to the biomaterial and controlled release society because it provides a new option for fabricating silk microspheres in one simple step of mixing silk and polyethylene glycol (PEG), with the size and properties of microspheres controllable by PEG molecular weight as well as PEG and silk concentrations. Although fabrication of silk microspheres have been reported previously using spray-drying, liposome-templating, polyvinyl alcohol (PVA) emulsification, etc., applications were hindered due to harsh conditions (temperature, solvents, etc.) and complicated procedures used as well as low yield and less controllable particle size (usually <10μm). Since PEG is an FDA-approved polymer, and silk is FDA approved for some medical devices, the methods developed in the present study will be useful in a variety of biomedical applications where simple, rapid and scalable preparation of silk microspheres is required.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silk-based biomaterials and applications · Quantum Dots Synthesis And Properties · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications10.2217/17435889.3.3.367 ↗
2. Polymer microspheres for controlled drug release10.1016/j.ijpharm.2004.04.013 ↗
3. Biodegradable microspheres for protein delivery10.1016/S0168-3659(03)00194-9 ↗
4. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives10.1016/j.jconrel.2007.09.013 ↗
5. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies10.1016/j.preteyeres.2014.04.002 ↗
6. Nanoparticles in cancer therapy and diagnosis10.1016/S0169-409X(02)00044-3 ↗
7. Natural polymers for gene delivery and tissue engineering10.1016/j.addr.2006.03.001 ↗
8. Precise control of PLG microspheres size provides enhanced control of drug release rate10.1016/S0168-3659(02)00136-0 ↗
9. In vitro and in vivo activities of leukotriene B4-loaded biodegradable microspheres10.1016/j.prostaglandins.2006.10.007 ↗
10. Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation10.1016/j.ijpharm.2012.10.044 ↗
11. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review10.1016/j.jconrel.2006.04.017 ↗
12. Degradation of poly(d,d-lactic acid) microspheres: effect of molecular weight10.1016/0168-3659(94)90263-1 ↗
13. Silk-based biomaterials10.1016/S0142-9612(02)00353-8 ↗
14. In vitro degradation of silk fibroin10.1016/j.biomaterials.2004.09.020 ↗
15. The inflammatory responses to silk films in vitro and in vivo10.1016/j.biomaterials.2004.02.047 ↗
16. Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency10.1016/j.biomaterials.2013.11.025 ↗
17. Materials fabrication from Bombyx mori silk fibroin10.1038/nprot.2011.379 ↗
18. Silk fibroin as an organic polymer for controlled drug delivery10.1016/j.jconrel.2005.12.009 ↗
19. Biomaterial films of Bombyx mori silk fibroin with poly(ethylene oxide)10.1021/bm0343287 ↗
20. Electrospun silk-BMP-2 scaffolds for bone tissue engineering10.1016/j.biomaterials.2006.01.022 ↗
21. New process to form a silk fibroin porous 3-D structure10.1021/bm050431f ↗
22. Silk coatings on PLGA and alginate microspheres for protein delivery10.1016/j.biomaterials.2007.05.036 ↗
23. The preparation of regenerated silk fibroin microspheres10.1039/b703139d ↗
24. Change in secondary structure of silk fibroin during preparation of its microspheres by spray-drying and exposure to humid atmosphere10.1016/S0021-9797(03)00584-8 ↗
25. Controlling silk fibroin particle features for drug delivery10.1016/j.biomaterials.2010.02.024 ↗
26. Synthesis of silk fibroin micro- and submicron spheres using a co-flow capillary device10.1002/adma.201304244 ↗
27. Silk microspheres for encapsulation and controlled release10.1016/j.jconrel.2006.11.021 ↗
28. Preparation and in vitro evaluation of silk fibroin microspheres produced by a novel ultra-fine particle processing system10.1016/j.ijpharm.2011.06.041 ↗
29. Silk fibroin spheres as a platform for controlled drug delivery10.1016/j.jconrel.2008.08.005 ↗
30. Preparation of porous silk fibroin microspheres by a water-in-oil emulsification-diffusion method10.1002/app.32506 ↗
31. Silk nanospheres and microspheres from silk/pva blend films for drug delivery10.1016/j.biomaterials.2009.11.002 ↗
32. Functionalized silk-based biomaterials for bone formation10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7 ↗
33. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain10.1073/pnas.1206210109 ↗
34. Structure and properties of silk hydrogels10.1021/bm0345460 ↗
35. Recombinant spider silk particles as drug delivery vehicles10.1016/j.biomaterials.2010.11.060 ↗
36. Determining beta-sheet crystallinity in fibrous proteins by thermal analysis and infrared spectroscopy10.1021/ma0610109 ↗
37. A mild process to design silk scaffolds with reduced β-sheet structure and various topographies at nanometer scale10.1016/j.actbio.2014.11.016 ↗
38. Study on silk I porous 3-D scaffolds10.4028/www.scientific.net/KEM.342-343.233 ↗
39. Study on extraction and separation of butyric acid from clostridium typobutyricum fermentation broth in PEG Na2SO4 aqueous two phase system10.1016/j.fluid.2015.05.047 ↗
40. Charge carrier dynamics in thiol capped CdTe quantum dots10.1039/b921130f ↗
41. Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals10.1021/cm034081k ↗
42. Injectable silk-polyethylene glycol hydrogels10.1016/j.actbio.2014.10.027 ↗
43. Safety of poly(ethylene glycol) and poly(ethylene glycol) derivatives10.1021/bk-1997-0680.ch004 ↗
44. Insoluble and flexible silk films containing glycerol10.1021/bm900993n ↗
45. Water-insoluble silk films with silk I structure10.1016/j.actbio.2009.10.041 ↗
46. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin10.1016/j.biomaterials.2004.07.044 ↗
47. Enhanced hydration stability of Bombyx mori silk fibroin/PEG 600 composite scaffolds for tissue engineering10.1002/pat.3282 ↗
48. Semiconductor nonocrystals as fluorescent biological labels10.1126/science.281.5385.2013 ↗
49. Noninvasive imaging of quantum dots in mice10.1021/bc034153y ↗
50. Incorporation of quantum dots into silk biomaterials for fluorescence imaging10.1039/C5TB00326A ↗
51. Fabrication and characterization of silk-fibroin-coated quantum dots10.1109/TNB.2009.2017295 ↗
52. Microsphere size influences the foreign body reaction10.22203/eCM.v028a23 ↗
53. Biocompatibility of poly(d,l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection10.1016/j.ijpharm.2014.12.014 ↗